<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399828</url>
  </required_header>
  <id_info>
    <org_study_id>02CBED0602</org_study_id>
    <nct_id>NCT00399828</nct_id>
  </id_info>
  <brief_title>Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite</brief_title>
  <official_title>Clinical Study For Evaluation Of The Efficacy and Safety Of Tri-ActiveTM (Deka M.E.L.A., Itália) In Treatment Of Cellulite</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brazilan Center for Studies in Dermatology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brazilan Center for Studies in Dermatology</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of device TRI-ACTIVETM (DEKA M.E.L.A.,
      Itália)in the treatment od cellulite and body contouring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study is a clinical, opened trial and single-center.

      The patients will be treated by six laser diodes, localised cooling system and rhythmical
      intake massage device. Application of the massage will be performed for 8 weeks in a total of
      16 treatment sessions: twice a week.

      A set of photographs will be taken at visit 1 (baseline), visit 2 and 3 with standardized
      positions and lighting conditions.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>August 2006</start_date>
  <completion_date>November 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of effectiveness of treatment based on current classification of cellulite and evaluation corporal measures</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of subject's satisfaction</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual assessments of the treated area before and after treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety analysis</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Cellulite</condition>
  <condition>Body Contouring</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TRI-ACTIVE LASERDERMOLOGYTM (DEKA M.E.L.A., Itália)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written Informed Consent;

          2. Subjects agreeing to take part of all procedures of the study (including mechanical
             massage, photographs), after being fully informed on the objectives and nature of the
             investigations;

          3. Female subjects between 18-45 years;

          4. Subjects presenting with cellulite grades I-III on buttocks and thighs;

          5. Medical history and physical examination which, based on the investigator's opinion,
             do not prevent the patient from taking part in the study and use the device under
             investigation;

          6. Female subjects of childbearing age should present a negative urine pregnancy test and
             should be using an effective contraceptive method (3 months before the enrollement
             untill the end of the study);

          7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0;

          8. Availability of the subject throughout the duration of the study (60 days);

          9. Availability of the subject in maintaining a stable weight during the study (variation
             less than 2 kg)

         10. Subjects with sufficient schooling and awareness to enable them to cooperate to the
             degree required by this protocol.

        Exclusion Criteria:

          1. Pregnant women or women intending to become pregnant during the study (next 3 months);

          2. BMI superior 25,0;

          3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis;

          4. Subjects participating in other clinical trials;

          5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled
             hypertension;

          6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises;

          7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be
             treated;

          8. Any prior aesthetic surgery affecting the area to be treated (liposuction,
             Subcision®), 3 months before the study, that may interfere with results;

          9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to
             the study;

         10. Subjects with inflammation or active infection in the area to be treated.

         11. Subjects with a history of adverse effects, which in the investigator's opinion should
             prevent the patient from participating in the study;

         12. Patients with cutaneous or vascular alterations, that difficult visualization and
             documentation of cellulite;

         13. Subjects with a history of medical treatment non-adherence or showing unwillingness to
             adhere to the study protocol;

         14. Subjects who can not come to the visits (one missing visit/ month is allowed);

         15. Subjects intending to initiate any intensive sport;

         16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics,
             corticosteroids, or diuretics;

         17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or
             self-tanning during the study;

         18. Any condition that, in the opinion of the investigator, can compromise the evaluation
             of the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Doris Hexsel</last_name>
    <role>Study Director</role>
    <affiliation>Brazilian Center fpr Dermatological Studies</affiliation>
  </overall_official>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2006</study_first_submitted>
  <study_first_submitted_qc>November 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2006</study_first_posted>
  <last_update_submitted>March 11, 2008</last_update_submitted>
  <last_update_submitted_qc>March 11, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cellulite</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

